Butorphanol
Structural formula | ||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
![]() |
||||||||||||||||||||||
General | ||||||||||||||||||||||
Non-proprietary name | Butorphanol | |||||||||||||||||||||
other names |
|
|||||||||||||||||||||
Molecular formula | C 21 H 29 NO 2 | |||||||||||||||||||||
Brief description |
white solid |
|||||||||||||||||||||
External identifiers / databases | ||||||||||||||||||||||
|
||||||||||||||||||||||
Drug information | ||||||||||||||||||||||
ATC code | ||||||||||||||||||||||
Drug class | ||||||||||||||||||||||
properties | ||||||||||||||||||||||
Molar mass | ||||||||||||||||||||||
Physical state |
firmly |
|||||||||||||||||||||
Melting point |
216 ° C (base) |
|||||||||||||||||||||
safety instructions | ||||||||||||||||||||||
|
||||||||||||||||||||||
Toxicological data |
35 μg kg −1 ( TD Lo , human (woman) , intraspinal , base) |
|||||||||||||||||||||
As far as possible and customary, SI units are used. Unless otherwise noted, the data given apply to standard conditions . |
Butorphanol is a strong pain reliever ( analgesic ) from the group of opioids . It acts as an agonist on the κ and δ opioid receptors and an antagonist on the μ − opioid receptor . Butorphanol is used as a veterinary medicinal product.
Finished medicinal products
Dolorex ad us.vet. ( D ), Torbugesic ad us.vet. (D)
literature
- Anne Rollmann: Examination of the analgesic potency of different dosages of butorphanol and buprenorphine after intravenous administration in dogs using a thermal and mechanical pain test (PDF; 893 kB) Dissertation, University of Veterinary Medicine Hannover, 2011.
Individual evidence
- ^ Martindale: The Complete Drug Reference . 36th edition. Pp. 1-32.
- ↑ a b Entry on butorphanol in the ChemIDplus database of the United States National Library of Medicine (NLM) .
- ↑ a b data sheet butorphanol (+) - tartrate salt, ≥99% from Sigma-Aldrich , accessed on June 10, 2020 ( PDF ).
- ↑ Entry on Butorphanol in Pharmawiki , accessed on January 28, 2017.